Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02LHR
|
|||
| Former ID |
DNC003773
|
|||
| Drug Name |
INDORAMIN
|
|||
| Synonyms |
INDORAMIN; Indoramine; 26844-12-2; Indoramina; Wy-21901; Indoraminum [INN-Latin]; Indoramine [INN-French]; Indoramina [INN-Spanish]; UNII-0Z802HMY7H; Baratol; EINECS 248-041-5; BRN 0494035; WY 21901; 0Z802HMY7H; CHEMBL279516; C22H25N3O; Benzamide, N-(1-(2-(1H-indol-3-yl)ethyl)-4-piperidinyl)-; 3-(2-(4-Benzamidopiperid-1-yl)ethyl)indole; JXZZEXZZKAWDSP-UHFFFAOYSA-N; N-(1-(2-Indol-3-ylethyl)-4-piperidyl)benzamide; N-(1-(2-(1H-Indol-3-yl)ethyl)-4-piperidinyl)benzamide; Benzamide, N-(1-(2-indol-3-ylethyl)-4-piperidyl)-; Benzamide, N
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Hypertension [ICD-11: BA00-BA04; ICD-9: 401] | Withdrawn from market | [1], [2] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H25N3O
|
|||
| Canonical SMILES |
C1CN(CCC1NC(=O)C2=CC=CC=C2)CCC3=CNC4=CC=CC=C43
|
|||
| InChI |
1S/C22H25N3O/c26-22(17-6-2-1-3-7-17)24-19-11-14-25(15-12-19)13-10-18-16-23-21-9-5-4-8-20(18)21/h1-9,16,19,23H,10-15H2,(H,24,26)
|
|||
| InChIKey |
JXZZEXZZKAWDSP-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 26844-12-2
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
3145511, 4954321, 7979608, 8173213, 11393053, 14778365, 26534678, 29217568, 34675413, 47206378, 47227712, 47301929, 47451424, 47747528, 47971029, 48345790, 49671666, 49876989, 50603739, 57311546, 85209952, 89765137, 92270335, 103006849, 103194521, 103941454, 104316511, 117564550, 124638943, 125163373, 125433253, 128343844, 134224549, 134340978, 134997857, 135650391, 136050062, 137248543, 141645446, 152133947, 162185578, 179150251, 184547504, 187071875, 198950576, 223519058, 224810415, 226433258, 226433259, 241046546
|
|||
| ChEBI ID |
CHEBI:135470
|
|||
| SuperDrug ATC ID |
C02CA02
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 501). | |||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 3 | Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification. J Med Chem. 1995 Sep 1;38(18):3415-44. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.